Google Jumps Into Gene Editing: 5 Things You Need to Know

Google makes so many side bets that it named its holding company Alphabet to remind investors that bold and risky investments are going to be a constant theme. One of Alphabet's newest bets is a gene-editing start-up, Verve Therapeutics, and it's teaming up with Google's long-running life science venture, Verily.